- 5F-APP-PINACA
- APP-5F-PINACA
- FU-PX
- PPA(N)-2201
- PX-2
- N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
- Nα-[1-(5-Fluoropentyl)-1H-indazole-3-carbonyl]-L-phenylalaninamide
Qian, Z; Jia, W; Li, T; Hua, Z; Liu, C. Identification and analytical characterization of four synthetic cannabinoids ADB-BICA, NNL-1, NNL-2, and PPA(N)-2201. Drug Test. Anal., 1 Jan 2017, 9 (1), 51-60. 1.3 MB. https://doi.org/10.1002/dta.1990 #4
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Hess, C; Murach, J; Krueger, L; Scharrenbroch, L; Unger, M; Madea, B; Sydow, K. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples. Drug Test. Anal., 1 May 2017, 9 (5), 721-733. 267 kB. https://doi.org/10.1002/dta.2030 #PX-2 LC,MS
Abbate, V; Schwenk, M; Presley, BC; Uchiyama, N. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure Appl. Chem., 28 Aug 2018, 90 (8), 1255–1282. 1.0 MB. https://doi.org/10.1515/pac-2017-0605 #8. PX-2